| 8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC N Ahmadiyeh, MM Pomerantz, C Grisanzio, P Herman, L Jia, V Almendro, ... Proceedings of the National academy of sciences 107 (21), 9742-9746, 2010 | 451 | 2010 |
| Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups OM Rueda, SJ Sammut, JA Seoane, SF Chin, JL Caswell-Jin, M Callari, ... Nature 567 (7748), 399-404, 2019 | 351 | 2019 |
| Change in survival in metastatic breast cancer with treatment advances: meta-analysis and systematic review JL Caswell-Jin, SK Plevritis, L Tian, CJ Cadham, C Xu, NK Stout, ... JNCI cancer spectrum 2 (4), pky062, 2018 | 309 | 2018 |
| Racial/ethnic differences in multiple-gene sequencing results for hereditary cancer risk JL Caswell-Jin, T Gupta, E Hall, IM Petrovchich, MA Mills, KE Kingham, ... Genetics in Medicine 20 (2), 234-239, 2018 | 190 | 2018 |
| Genome-wide association study of breast cancer in Latinas identifies novel protective variants on 6q25 L Fejerman, N Ahmadiyeh, D Hu, S Huntsman, KB Beckman, JL Caswell, ... Nature communications 5 (1), 5260, 2014 | 153 | 2014 |
| Analysis of chimpanzee history based on genome sequence alignments JL Caswell, S Mallick, DJ Richter, J Neubauer, C Schirmer, S Gnerre, ... PLoS genetics 4 (4), e1000057, 2008 | 122 | 2008 |
| Cascade genetic testing of relatives for hereditary cancer risk: results of an online initiative JL Caswell-Jin, AD Zimmer, W Stedden, KE Kingham, AY Zhou, ... JNCI: Journal of the National Cancer Institute 111 (1), 95-98, 2019 | 120 | 2019 |
| Spatial proteomic characterization of HER2-positive breast tumors through neoadjuvant therapy predicts response KL McNamara, JL Caswell-Jin, R Joshi, Z Ma, E Kotler, GR Bean, ... Nature cancer 2 (4), 400-413, 2021 | 77 | 2021 |
| Natural language processing approaches to detect the timeline of metastatic recurrence of breast cancer I Banerjee, S Bozkurt, JL Caswell-Jin, AW Kurian, DL Rubin JCO clinical cancer informatics 3, 1-12, 2019 | 70 | 2019 |
| Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy JL Caswell-Jin, K McNamara, JG Reiter, R Sun, Z Hu, Z Ma, J Ding, ... Nature communications 10 (1), 657, 2019 | 62 | 2019 |
| Analysis of breast cancer mortality in the US—1975 to 2019 JL Caswell-Jin, LP Sun, D Munoz, Y Lu, Y Li, H Huang, JM Hampton, ... JAMA 331 (3), 233-241, 2024 | 61 | 2024 |
| Using natural language processing to construct a metastatic breast cancer cohort from linked cancer registry and electronic medical records data AY Ling, AW Kurian, JL Caswell-Jin, GW Sledge Jr, NH Shah, ... JAMIA open 2 (4), 528-537, 2019 | 57 | 2019 |
| Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients E Ziv, E Dean, D Hu, A Martino, D Serie, K Curtin, D Campa, B Aftab, ... Nature communications 6 (1), 7539, 2015 | 54 | 2015 |
| Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07) SA Hurvitz, JL Caswell-Jin, KL McNamara, JJ Zoeller, GR Bean, ... Nature communications 11 (1), 5824, 2020 | 51 | 2020 |
| Chromatin regulators mediate anthracycline sensitivity in breast cancer JA Seoane, JG Kirkland, JL Caswell-Jin, GR Crabtree, C Curtis Nature medicine 25 (11), 1721-1727, 2019 | 40 | 2019 |
| Prevalence of pathogenic variants in cancer susceptibility genes among women with postmenopausal breast cancer AW Kurian, R Bernhisel, K Larson, JL Caswell-Jin, AH Shadyab, ... Jama 323 (10), 995-997, 2020 | 39 | 2020 |
| Performance of the IBIS/Tyrer‐Cuzick model of breast cancer risk by race and ethnicity in the Women's Health Initiative AW Kurian, E Hughes, T Simmons, R Bernhisel, B Probst, S Meek, ... Cancer 127 (20), 3742-3750, 2021 | 37 | 2021 |
| Multiple breast cancer risk variants are associated with differential transcript isoform expression in tumors JL Caswell, R Camarda, AY Zhou, S Huntsman, D Hu, SE Brenner, ... Human Molecular Genetics 24 (25), 7421-7431, 2015 | 34 | 2015 |
| Breast cancer diagnosis and treatment during the COVID-19 pandemic in a nationwide, insured population JL Caswell-Jin, MN Shafaee, L Xiao, M Liu, EM John, ML Bondy, ... Breast Cancer Research and Treatment 194 (2), 475-482, 2022 | 24 | 2022 |
| Molecular heterogeneity and evolution in breast cancer JL Caswell-Jin, C Lorenz, C Curtis Annual Review of Cancer Biology 5 (1), 79-94, 2021 | 23 | 2021 |
Christina CurtisStanford UniversityVerified email at stanford.edu